Biosensor Activated Biomanufacturing Scale-up
Enduro aims to revolutionize microbial biomanufacturing with its synthetic biology plugin, Enduro Sense, to enable scalable processes and attract investment for commercial deployment.
Projectdetails
Introduction
Industrial Biotechnology is one of the Key Enabling Technologies (KETs) identified by Europe. Harnessing the power of microbes for biomanufacturing is one of the most promising approaches to providing a sustainable alternative to a fossil fuel- and animal farming-based economy.
Challenges in Biomanufacturing
However, fermentation scale-up remains a massive challenge to the commercialization of bioprocesses, ultimately hindering the sector from reaching its potential.
Innovative Solution
Enduro has developed a game-changing synthetic biology plugin – Enduro Sense – to bridge the scale-up gap and enable cheaper and scalable continuous microbial biomanufacturing.
Next Steps
After successful developments, we are ready to perform large-scale demonstrations with commercial strains from industrial partners, achieving a key milestone that will unlock further investments to finance the commercial deployment of the technology.
Importance of Funding
This EIC grant is crucial to position our company in a market that is rapidly evolving.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.815.295 |
Totale projectbegroting | € 2.593.279 |
Tijdlijn
Startdatum | 1-4-2023 |
Einddatum | 31-3-2025 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- ENDURO GENETICS APSpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Commercial feasibility of a cell-free reactor setup for optimisation of complex enzymatic pathwaysThis project aims to commercialize a continuous stirred tank reactor for optimizing complex enzymatic pathways, enhancing production efficiency and establishing a viable commercialization strategy. | ERC POC | € 150.000 | 2022 | Details |
Metaraminol Demonstration Plant as Commercialisation Blueprint for Sustainable Production of Pharmaceuticals using Enzyme Cascades'SusECAS - DemoPlant' aims to establish a sustainable, biocatalytic process for producing amino alcohols in Europe, enhancing ecological and economic viability while facilitating market entry. | ERC POC | € 150.000 | 2022 | Details |
Translating a new metabolic engineering strategy to industrial biotech applicationsThe TRANSMETECH project aims to translate the StrainBooster metabolic engineering strategy into industrial applications, enhancing bioprocess efficiency for sustainable chemical production. | ERC POC | € 150.000 | 2023 | Details |
TUNGSTEN BIOCATALYSIS – HEAVY METAL ENZYMES FOR SUSTAINABLE INDUSTRIAL BIOCATALYSISThis project aims to develop a new W-cofactor biosynthesis pathway in E. coli to produce tungsten-containing enzymes for sustainable chemical processes, enabling efficient CO2 reduction and cosmetic ingredient production. | EIC Pathfinder | € 2.430.574 | 2024 | Details |
Commercial feasibility of a cell-free reactor setup for optimisation of complex enzymatic pathways
This project aims to commercialize a continuous stirred tank reactor for optimizing complex enzymatic pathways, enhancing production efficiency and establishing a viable commercialization strategy.
Metaraminol Demonstration Plant as Commercialisation Blueprint for Sustainable Production of Pharmaceuticals using Enzyme Cascades
'SusECAS - DemoPlant' aims to establish a sustainable, biocatalytic process for producing amino alcohols in Europe, enhancing ecological and economic viability while facilitating market entry.
Translating a new metabolic engineering strategy to industrial biotech applications
The TRANSMETECH project aims to translate the StrainBooster metabolic engineering strategy into industrial applications, enhancing bioprocess efficiency for sustainable chemical production.
TUNGSTEN BIOCATALYSIS – HEAVY METAL ENZYMES FOR SUSTAINABLE INDUSTRIAL BIOCATALYSIS
This project aims to develop a new W-cofactor biosynthesis pathway in E. coli to produce tungsten-containing enzymes for sustainable chemical processes, enabling efficient CO2 reduction and cosmetic ingredient production.